Edition:
United States

InVivo Therapeutics Holdings Corp (NVIV.OQ)

NVIV.OQ on NASDAQ Stock Exchange Capital Market

1.93USD
10 Dec 2018
Change (% chg)

$-0.09 (-4.46%)
Prev Close
$2.02
Open
$2.01
Day's High
$2.01
Day's Low
$1.92
Volume
6,329
Avg. Vol
34,086
52-wk High
$25.75
52-wk Low
$1.64

Chart for

About

InVivo Therapeutics Holdings Corp., formerly Design Source, Inc., is a research and clinical-stage biomaterials and biotechnology company. The Company is engaged in developing and commercializing biopolymer-scaffolding devices for the treatment of spinal cord injuries (SCI). The Company's approach to treating acute SCIs is based... (more)

Overall

Beta: 3.34
Market Cap(Mil.): $53.11
Shares Outstanding(Mil.): 32.18
Dividend: --
Yield (%): --

Financials

  NVIV.OQ Industry Sector
P/E (TTM): -- 195.05 33.63
EPS (TTM): -0.76 -- --
ROI: -83.17 9.63 15.02
ROE: -86.11 15.55 16.60

Earnings vs. Estimates